Revista Medica Clinica Las Condes最新文献

筛选
英文 中文
Asma y embarazo: fisiopatología, diagnóstico y manejo farmacológico 哮喘与妊娠:病理生理学、诊断和药物治疗
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.05.001
Paulina Barría
{"title":"Asma y embarazo: fisiopatología, diagnóstico y manejo farmacológico","authors":"Paulina Barría","doi":"10.1016/j.rmclc.2024.05.001","DOIUrl":"10.1016/j.rmclc.2024.05.001","url":null,"abstract":"<div><p>Bronchial asthma is considered one of the most common chronic pathologies in pregnancy, affecting between 6 to 10% of pregnant women according to international reports. In this group of patients, approximately one third will present a significant aggravation in asthma symptoms, exposing the mother and fetus to a high risk of exacerbations and use of systemic corticosteroids. Poor control of asthma symptoms is in many cases due to suspension or suboptimal therapy with inhaled corticosteroid, which constitutes the basis of anti-inflammatory and controller therapy in asthma. It has been shown that poorly controlled asthma during pregnancy increases the risk of obstetric complications. The respiratory management of these patients must be proactive, patient education based and with informed use of anti-asthmatic treatments, which are highly effective and, for most patients, easily accessible. This article will review the pathophysiology, diagnosis and pharmacological management of asthma in pregnancy.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 221-231"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000324/pdfft?md5=44464a63899bdc55d621920ffe5516bc&pid=1-s2.0-S0716864024000324-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enfoque diagnóstico en el paciente con derrame pleural 胸腔积液患者的诊断方法
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.05.010
Maite Oyonarte W.
{"title":"Enfoque diagnóstico en el paciente con derrame pleural","authors":"Maite Oyonarte W.","doi":"10.1016/j.rmclc.2024.05.010","DOIUrl":"10.1016/j.rmclc.2024.05.010","url":null,"abstract":"<div><p>The diagnostic approach in patients with pleural effusion requires considering clinical aspects, fluid analysis, and, often, pleural biopsy. Currently, several procedures con be performed at the same time to speed up the diagnostic process, ideally in an outpatient setting. This article aims to describe the state of the art with regards to the diagnostic process.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 299-308"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000440/pdfft?md5=e369eeff4c1df8639750f465fcd6a10a&pid=1-s2.0-S0716864024000440-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uso correcto de inhaladores en adultos: del conocimiento a la aplicación 成人正确使用吸入器:从认知到应用
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.07.002
Carlos Horta , Loreto Sáez , Jorge Jorquera
{"title":"Uso correcto de inhaladores en adultos: del conocimiento a la aplicación","authors":"Carlos Horta ,&nbsp;Loreto Sáez ,&nbsp;Jorge Jorquera","doi":"10.1016/j.rmclc.2024.07.002","DOIUrl":"10.1016/j.rmclc.2024.07.002","url":null,"abstract":"<div><p>The administration of drugs via inhalation has become the primary route for treating obstructive pulmonary diseases. In this context, the efficient deposition of medication particles in the airway plays a fundamental role in the effectiveness of inhaled therapy, offering superior benefits in terms of speed and reduction of systemic effects compared to other routes of administration. It is crucial to ensure that a sufficient amount of medication reaches beyond the oropharyngeal region to guarantee therapeutic effectiveness. Among the available devices for this form of administration, pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs) are the most commonly used. It is worth mentioning that nebulization devices are not covered in this review.</p><p>Although the diversity of therapeutic options is beneficial, the availability of different devices can create some complexity when instructing patients on their proper use. Consequently, it is vital for patients to precisely follow the recommended inhalation technique. Errors in device handling can lead to improper drug distribution, reducing the effective dose and compromising treatment efficacy. This review provides detailed explanations of the mechanism of action of these devices, as well as practical instructions for patient care personnel. Emphasis is placed on the importance of correct inhalation technique to maximize treatment efficacy and ensure optimal drug use.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 190-200"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000518/pdfft?md5=e855c06c6391ddb92c081ad2cf65c13a&pid=1-s2.0-S0716864024000518-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neumonía grave por Influenza H1N1 ¿qué aprendimos desde el 2009? 重症甲型 H1N1 流感肺炎:自 2009 年以来我们学到了什么?
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.07.005
Felipe Reyes-Cartes , Claudio Pérez-Oliva , Andrés Ramos-Plata
{"title":"Neumonía grave por Influenza H1N1 ¿qué aprendimos desde el 2009?","authors":"Felipe Reyes-Cartes ,&nbsp;Claudio Pérez-Oliva ,&nbsp;Andrés Ramos-Plata","doi":"10.1016/j.rmclc.2024.07.005","DOIUrl":"10.1016/j.rmclc.2024.07.005","url":null,"abstract":"<div><p>The influenza A(H1N1) pandemic of 2009 marked a pivotal event in the 21st century, as it was recognized as the first pandemic of that era, once again highlighting the vulnerability of populations to respiratory viruses. This article aims to explore the lessons learned from the Influenza A H1N1 pandemic, particularly pertinent to the current epidemiological landscape. Viral characteristics, pathogenesis, clinical symptoms, and associated risk factors were analyzed. Additionally, the significance of early antiviral therapy, potential adverse effects linked to corticosteroid use, and non-viral infectious complications, such as necrotizing pneumonia caused by Staphylococcus aureus and streptococcal toxic shock syndrome, were examined. This review aspires to be a valuable resource for understanding and addressing influenza-induced pneumonia and its complications from prevention to treatment.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 309-318"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000543/pdfft?md5=4107236aff5f6e62b99179ec34d251c6&pid=1-s2.0-S0716864024000543-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enfermedades reumatológicas y compromiso pulmonar, lo que hay que saber 风湿病与肺部受累,您需要了解的知识
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.05.005
Silvana Saavedra , Felipe Reyes-Cartes
{"title":"Enfermedades reumatológicas y compromiso pulmonar, lo que hay que saber","authors":"Silvana Saavedra ,&nbsp;Felipe Reyes-Cartes","doi":"10.1016/j.rmclc.2024.05.005","DOIUrl":"10.1016/j.rmclc.2024.05.005","url":null,"abstract":"<div><p>Connective tissue diseases and vasculitis are a wide group of autoimmune pathologies that can affect multiple organs. One of the most frequently affected systems is the respiratory system, with compromise of the airway, lung parenchyma, pleura and mediastinum. These pathologies constitute an important cause of morbimortality, making it essencial to maintain a high clinical suspicion.</p><p>Furthermore, it is of vital relevance to rule out other causes of affectation like adverse drug reactions and infections due to the immunosuppressed state of patients with rheumatic diseases.</p><p>Both the classification and its management must be done by a multidisciplinary team, based on the clinical history, serology, lung function tests, high-resolution computed tomography, bronchoalveolar lavage and/or biopsy, depending on each case.</p><p>This review article aims to highlight the importance of a multidisciplinary approach in the management of connective tissue diseases and vasculitis; complex pathologies that can affect the respiratory system, constituting an important cause of morbidity and mortality. The classification and management of these conditions should be carried out by a multidisciplinary team, based on clinical status, laboratory tests, pulmonary function tests, imaging studies, and biopsies, according to each case.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 262-272"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000361/pdfft?md5=da14d1812ed9d524b9f31801ed58e7d4&pid=1-s2.0-S0716864024000361-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cómo calificar el índice de gravedad en la apnea obstructiva del sueño 如何评定阻塞性睡眠呼吸暂停的严重程度指数
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.05.006
Gonzalo Labarca , Mario Henríquez-Beltrán
{"title":"Cómo calificar el índice de gravedad en la apnea obstructiva del sueño","authors":"Gonzalo Labarca ,&nbsp;Mario Henríquez-Beltrán","doi":"10.1016/j.rmclc.2024.05.006","DOIUrl":"10.1016/j.rmclc.2024.05.006","url":null,"abstract":"<div><p>Currently, obstructive sleep apnea (OSA) is defined as having an apnea-hypopnea index (AHI) of 5 events per hour. The AHI is based on the frequency of respiratory events over time and is used to predict disease severity and guide therapeutic interventions. However, the AHI fails to capture the substantial heterogeneity present in OSA, including patterns of hypoxemia, sympathetic response, and gender differences. In recent years, multiple metrics derived from pulse oximeter signals, heart rate, electroencephalogram, and ventilation signals have been described. This article will focus on those metrics that have been validated through external studies and possess greater clinical relevance.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 273-280"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000373/pdfft?md5=8518e80cd5b46f673eb24b07c09f8506&pid=1-s2.0-S0716864024000373-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terapia farmacológica de primera línea en cesación tabáquica 戒烟的一线药物疗法
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.07.001
María Guacolda Benavides
{"title":"Terapia farmacológica de primera línea en cesación tabáquica","authors":"María Guacolda Benavides","doi":"10.1016/j.rmclc.2024.07.001","DOIUrl":"10.1016/j.rmclc.2024.07.001","url":null,"abstract":"<div><p>The current standard for smoking cessation is combined psychological and pharmacological treatment. Administering a drug to stop smoking in isolation (8-10% abstinence per year) is not the same as using it together with support and behavioral intervention (more than 30% abstinence). The fundamental reason drugs are used in the process of quitting smoking is because it has been proven that their use not only mitigates withdrawal symptoms but also increases long term quit rates (6-12 months). Varenicline, nicotine replacement therapy (NRT), bupropion and cytisine are all more effective than placebo. In very dependent smokers, a combination of drugs is recommended, with those associations containing varenicline being more effective. In special populations (chronic respiratory diseases, cardiovascular diseases or psychiatric pathology), varenicline alone or combined with NRT is recommended as the first option. Finally, it is important to highlight that the fact that a previous unsuccessful attempt to stop smoking with a certain drug is not a contraindication for its subsequent use since success depends on many factors, such as; correct usage of the drug, motivational stage, presence of environmental obstacles and a firm decision to quit smoking, among others.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 161-168"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000506/pdfft?md5=e0ccbfe3abbba6bbfd90321e4d122aef&pid=1-s2.0-S0716864024000506-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculosis: estado actual 结核病:现状
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.06.001
Juan Carlos Rodríguez-Duque
{"title":"Tuberculosis: estado actual","authors":"Juan Carlos Rodríguez-Duque","doi":"10.1016/j.rmclc.2024.06.001","DOIUrl":"10.1016/j.rmclc.2024.06.001","url":null,"abstract":"<div><p>The objective of this work is to offer an updated review of pulmonary tuberculosis; covering epidemiological aspects, pathogenesis, clinical presentation, diagnosis and current therapy.</p><p>Active tuberculosis is addressed in its different clinical forms. Likewise, the concept of latent and subclinical tuberculosis is analyzed. An update of diagnostic methods and therapy of active tuberculosis, both sensitive and resistant to antibiotics, is made.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 169-177"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000439/pdfft?md5=14dfb2fb35a7068b2d4ca9f8c46fefd4&pid=1-s2.0-S0716864024000439-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actualizaciones clínicas en enfermedades pulmonares intersticiales: estrategias diagnósticas y terapéuticas avanzadas 间质性肺病的临床最新进展:先进的诊断和治疗策略
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.05.004
Felipe Reyes-Cartes
{"title":"Actualizaciones clínicas en enfermedades pulmonares intersticiales: estrategias diagnósticas y terapéuticas avanzadas","authors":"Felipe Reyes-Cartes","doi":"10.1016/j.rmclc.2024.05.004","DOIUrl":"10.1016/j.rmclc.2024.05.004","url":null,"abstract":"<div><p>Interstitial lung diseases (ILDs) are a heterogeneous group of disorders that affect the lung interstitium, characterized by inflammation and/or fibrosis. Historically, they were based on histopathological characteristics of lung biopsies, but with the advancement of high-resolution computed tomography (HRCT), the approach has shifted, allowing for the identification of disease patterns that suggest different etiologies. The classification of ILDs has evolved, and they are currently classified according to etiology, histopathological and/or radiological patterns, and evolutionary course. Idiopathic interstitial pneumonias (IIPs) are a group of ILDs of unknown origin, with idiopathic pulmonary fibrosis (IPF) being the most common within the IIPs. The concept of progressive fibrosing interstitial lung disease (PF-ILD) has been developed, describing a phenotype of ILD with progression despite treatment. Diagnosis is based on a detailed clinical history, physical examination, pulmonary function tests, autoimmune serology, and imaging techniques such as HRCT. Treatment varies according to etiology and may include immunomodulatory or anti-inflammatory therapy, disease-modifying therapy with antifibrotic agents and, in advanced cases, lung transplantation. Medical care should be holistic, including pulmonary rehabilitation, infection prevention, and oxygen therapy. This article aims to provide a clinical update on interstitial lung diseases and comment on advances in diagnostic and therapeutic strategies.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 241-254"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S071686402400035X/pdfft?md5=d576d7b5c16b89c315eb6ae755c40254&pid=1-s2.0-S071686402400035X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“El saxofonista” "萨克斯手
IF 0.2
Revista Medica Clinica Las Condes Pub Date : 2024-05-01 DOI: 10.1016/j.rmclc.2024.08.002
{"title":"“El saxofonista”","authors":"","doi":"10.1016/j.rmclc.2024.08.002","DOIUrl":"10.1016/j.rmclc.2024.08.002","url":null,"abstract":"","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Page 376"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000580/pdfft?md5=6a212384b43352e004d007103eac6536&pid=1-s2.0-S0716864024000580-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信